Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- mixed respiratory vaccine
- Opdualag (nivolumab / relatlimab)
Interactions between your drugs
mixed respiratory vaccine nivolumab
Applies to: mixed respiratory vaccine, Opdualag (nivolumab / relatlimab)
If you are currently being treated or are going to begin treatment with nivolumab, you should let your doctor know before receiving mixed respiratory vaccine. Nivolumab can cause potentially serious immune-related side effects and receiving mixed respiratory vaccine during treatment with nivolumab may increase that risk. Your healthcare provider may already be aware of the risks but has determined that this is the best course of treatment for you and is monitoring you closely for any potential complications. You should seek immediate medical attention if you experience severe diarrhea; serious skin reactions such as a widespread rash, peeling skin, or blisters; signs of liver problems like yellowing of your skin or eyes, or pain on the right side of your abdomen; lung issues such as shortness of breath, chest pain, coughing, or extreme fatigue; kidney problems like difficulty urinating, sudden weight gain, or swelling in your feet, ankles, or legs; or thyroid and other endocrine issues such as fatigue, sluggishness, constipation, depression, hoarseness, or unexplained weight gain.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Bexsero
Bexsero is used for meningitis, meningococcal, meningococcal disease prophylaxis
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Biothrax
BioThrax is used to help prevent anthrax in people exposed to the bacteria through the skin or ...
Capvaxive
Capvaxive (pneumococcal 21-valent conjugate vaccine) is a single-dose vaccine that may be used to ...
Cyfendus
Cyfendus (anthrax vaccine adsorbed, adjuvanted) is a vaccine indicated for the post-exposure ...
Hiberix
Hiberix vaccine is used to prevent infection caused by haemophilus B bacteria. Learn about side ...
Liquid PedvaxHIB
Liquid PedvaxHIB is used for haemophilus influenzae prophylaxis
Menactra
Menactra is used to prevent infection caused by meningococcal bacteria. Learn about side effects ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.